Birchview Capital, LP Diversified Active

Location: Burlington, VT

CIK: 0001618205 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $214M (100.0% shares, 0.0% debt)

Holdings (73)

KLAC KLA CORPORATION 25.2%
Value $53.85M Shares 178,471 Est. Cost Unrealized
BMY BRISTOL-MYERS SQUIBB CO 8.0%
Value $17.13M Shares 297,243 Est. Cost Unrealized
LRCX LAM RESEARCH CORPORATION 7.1%
Value $15.17M Shares 35,000 Est. Cost Unrealized
SLDB SOLID BIOSCIENCES INC 3.1%
Value $6.655M Shares 666,196 Est. Cost Unrealized
NTLA INTELLIA THERAPEUTICS INC 3.0%
Value $6.521M Shares 385,400 Est. Cost Unrealized
BIODESIX INC 3.0%
Value $6.467M Shares 286,804 Est. Cost Unrealized
STOK STOKE THERAPEUTICS INC 2.7%
Value $5.828M Shares 178,110 Est. Cost Unrealized
OVV OVINTIV INC 2.6%
Value $5.66M Shares 107,500 Est. Cost Unrealized
NKTR NEKTAR THERAPEUTICS 2.6%
Value $5.655M Shares 81,000 Est. Cost Unrealized
CORT CORCEPT THERAPEUTICS INC 2.3%
Value $4.974M Shares 57,200 Est. Cost Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 2.1%
Value $4.582M Shares 27,190 Est. Cost Unrealized
PRTA PROTHENA CORP PLC 2.1%
Value $4.396M Shares 449,019 Est. Cost Unrealized
ACAD ACADIA PHARMACEUTICALS INC 2.0%
Value $4.326M Shares 171,000 Est. Cost Unrealized
PTGX PROTAGONIST THERAPEUTICS INC 2.0%
Value $4.293M Shares 35,018 Est. Cost Unrealized
CMPX COMPASS THERAPEUTICS INC 1.7%
Value $3.668M Shares 1,675,000 Est. Cost Unrealized
RLMD RELMADA THERAPEUTICS INC 1.3%
Value $2.824M Shares 408,100 Est. Cost Unrealized
ALKS ALKERMES PLC 1.2%
Value $2.62M Shares 50,000 Est. Cost Unrealized
HALO HALOZYME THERAPEUTICS INC 1.2%
Value $2.603M Shares 33,251 Est. Cost Unrealized
CLDX CELLDEX THERAPEUTICS INC 1.2%
Value $2.601M Shares 69,900 Est. Cost Unrealized
CYTK CYTOKINETICS INC 1.2%
Value $2.556M Shares 30,000 Est. Cost Unrealized
OLMA OLEMA PHARMACEUTICALS INC 1.2%
Value $2.489M Shares 199,000 Est. Cost Unrealized
VERA VERA THERAPEUTICS INC 1.2%
Value $2.478M Shares 57,758 Est. Cost Unrealized
UTHR UNITED THERAPEUTICS CORP 1.1%
Value $2.441M Shares 4,506 Est. Cost Unrealized
ZBIO ZENAS BIOPHARMA INC 1.1%
Value $2.376M Shares 93,601 Est. Cost Unrealized
QURE UNIQURE NV 1.1%
Value $2.335M Shares 50,697 Est. Cost Unrealized
PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC 1.1%
Value $2.268M Shares 1,350,000 Est. Cost Unrealized
ABVX ABIVAX SA 1.1%
Value $2.265M Shares 17,000 Est. Cost Unrealized
VIR VIR BIOTECHNOLOGY INC 1.0%
Value $2.242M Shares 220,000 Est. Cost Unrealized
BIIB BIOGEN INC 0.9%
Value $1.945M Shares 9,000 Est. Cost Unrealized
EQT EQT CORPORATION 0.9%
Value $1.841M Shares 34,619 Est. Cost Unrealized
BIOA BIOAGE LABS INC 0.8%
Value $1.691M Shares 69,000 Est. Cost Unrealized
TVTX TRAVERE THERAPEUTICS INC 0.8%
Value $1.647M Shares 29,000 Est. Cost Unrealized
QUIDELORTHO CORP 0.7%
Value $1.565M Shares 89,377 Est. Cost Unrealized
AXSM AXSOME THERAPEUTICS INC 0.7%
Value $1.469M Shares 6,000 Est. Cost Unrealized
FHTX FOGHORN THERAPEUTICS INC 0.6%
Value $1.376M Shares 281,937 Est. Cost Unrealized
BCYC BICYCLE THERAPEUTICS PLC 0.6%
Value $1.33M Shares 313,616 Est. Cost Unrealized
GPCR STRUCTURE THERAPEUTICS INC 0.6%
Value $1.288M Shares 24,000 Est. Cost Unrealized
XENE XENON PHARMACEUTICALS INC 0.6%
Value $1.269M Shares 21,032 Est. Cost Unrealized
NVO NOVO NORDISK A/S 0.5%
Value $1.151M Shares 24,000 Est. Cost Unrealized
FCX FREEPORT-MCMORAN CL-B 0.5%
Value $1.134M Shares 18,035 Est. Cost Unrealized
IMNM IMMUNOME INC 0.5%
Value $1.06M Shares 50,000 Est. Cost Unrealized
PHVS PHARVARIS N V 0.5%
Value $1.032M Shares 29,847 Est. Cost Unrealized
HROW HARROW HEALTH INC 0.5%
Value $1.019M Shares 24,000 Est. Cost Unrealized
ADAG ADAGENE INC 0.5%
Value $1.008M Shares 240,000 Est. Cost Unrealized
DFTX DEFINIUM THERAPEUTICS INC 0.4%
Value $941K Shares 20,000 Est. Cost Unrealized
SLN SILENCE THERAPEUTICS PLC 0.4%
Value $782K Shares 71,218 Est. Cost Unrealized
BBIO BRIDGEBIO PHARMA INC 0.3%
Value $651K Shares 8,741 Est. Cost Unrealized
FDMT 4D MOLECULAR THERAPEUTICS INC 0.3%
Value $645K Shares 48,505 Est. Cost Unrealized
URGN UROGEN PHARMA LTD 0.3%
Value $607K Shares 16,487 Est. Cost Unrealized
PHAT PHATHOM PHARMACEUTICALS INC 0.3%
Value $597K Shares 55,000 Est. Cost Unrealized
CAMP CAMP4 THERAPEUTICS CORP 0.2%
Value $524K Shares 120,000 Est. Cost Unrealized
SVRA SAVARA INC 0.2%
Value $493K Shares 80,000 Est. Cost Unrealized
CADL CANDEL THERAPEUTICS INC 0.2%
Value $492K Shares 47,756 Est. Cost Unrealized
ALT ALTIMMUNE INC 0.2%
Value $464K Shares 152,681 Est. Cost Unrealized
CMPS COMPASS PATHWAYS LTD 0.2%
Value $425K Shares 30,000 Est. Cost Unrealized
KARYOPHARM THERAPEUTICS INC 0.2%
Value $420K Shares 42,952 Est. Cost Unrealized
CGEM CULLINAN THERAPEUTICS INC 0.2%
Value $364K Shares 20,000 Est. Cost Unrealized
TRIN TRINITY CAP INC 0.2%
Value $358K Shares 20,000 Est. Cost Unrealized
CAPR CAPRICOR THERAPEUTICS INC 0.2%
Value $346K Shares 14,352 Est. Cost Unrealized
CSTL CASTLE BIOSCIENCES INC 0.1%
Value $310K Shares 12,984 Est. Cost Unrealized
IVVD INVIVYD INC 0.1%
Value $299K Shares 342,275 Est. Cost Unrealized
GRCE GRACE THERAPEUTICS INC 0.1%
Value $272K Shares 120,000 Est. Cost Unrealized
KBDC KAYNE ANDERSON BDC INC 0.1%
Value $271K Shares 20,000 Est. Cost Unrealized
VYGR VOYAGER THERAPEUTICS INC 0.1%
Value $263K Shares 75,147 Est. Cost Unrealized
LUNG PULMONX CORP 0.1%
Value $261K Shares 200,543 Est. Cost Unrealized
NTLA INTELLIA THERAPEUTICS INC (NTLA) C @ 13.0 10/16/2026 0.1%
Value $260K Shares 500 Est. Cost Unrealized
OCUL OCULAR THERAPEUTIX INC 0.1%
Value $203K Shares 20,655 Est. Cost Unrealized
KYNB KYNTRA BIO INC 0.1%
Value $170K Shares 22,566 Est. Cost Unrealized
ELUT ELUTIA INC 0.1%
Value $162K Shares 165,094 Est. Cost Unrealized
QNRX QUOIN PHARMACEUTICALS LTD 0.0%
Value $96,800 Shares 20,000 Est. Cost Unrealized
LPCN LIPOCINE INC 0.0%
Value $42,783 Shares 16,712 Est. Cost Unrealized
DCGO DOCGO INC 0.0%
Value $20,160 Shares 39,062 Est. Cost Unrealized
GOSS GOSSAMER BIO INC 0.0%
Value $2,992 Shares 18,176 Est. Cost Unrealized